Celldex Therapeutics
CLDX
CLDX
130 hedge funds and large institutions have $645M invested in Celldex Therapeutics in 2020 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
38% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 24
35% more capital invested
Capital invested by funds: $477M → $645M (+$168M)
11.99% more ownership
Funds ownership: 81.05% → 93.04% (+12%)
Holders
130
Holding in Top 10
3
Calls
$11.8M
Puts
$8.52M
Top Buyers
| 1 | +$31.3M | |
| 2 | +$24M | |
| 3 | +$23.3M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$18M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$12.7M |
Top Sellers
| 1 | -$45.5M | |
| 2 | -$17.8M | |
| 3 | -$12.1M | |
| 4 |
O
OrbiMed
New York
|
-$9.27M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$7.93M |